復星醫藥(600196.SH)、子公司與星輝安盈等共同投資設立南京復鑫
格隆匯 10 月 23日丨復星醫藥(600196.SH)公佈,公司、控股子公司上海復健股權投資基金管理有限公司(“復健基金管理公司”)與寧波梅山保税港區星輝安盈投資管理合夥企業(有限合夥)(“星輝安盈”)、關聯方上海復星高科技(集團)有限公司(“復星高科技”)擬分別出資人民幣444萬元、人民幣10萬元、人民幣250萬元和人民幣296萬元共同投資設立南京復鑫股權投資管理合夥企業(有限合夥)(暫定名,最終以登記機關核准為準;“南京復鑫”)。南京復鑫設立後,公司、復健基金管理公司、星輝安盈和復星高科技將分別持有其44.4%、1%、25%和29.6%的財產份額。
為加強大健康產業佈局,集團擬集合內外部資源、發起設立股權投資基金並投資生物醫藥、醫療器械及診斷、生物材料、精準治療等領域項目。南京復鑫系集團為發起股權投資基金而設立的出資及管理平台。此次交易完成後,南京復鑫將納入集團合併報表範圍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.